asparagine has been researched along with Gram-Positive Bacterial Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Béné, MC; Bonmati, C; Bories, P; Boulland, ML; Bouscary, D; Chevallier, P; Deconinck, E; Dombret, H; Escoffre-Barbe, M; Godfrin, Y; Himberlin, C; Huguet, F; Hunault-Berger, M; Ifrah, N; Lafage-Pochitaloff, M; Legrand, O; Leguay, T; Leprêtre, S; Liens, D; Lissandre, S; Ojeda-Uribe, M; Reman, O; Rousselot, P; Sanhes, L; Turlure, P | 1 |
1 trial(s) available for asparagine and Gram-Positive Bacterial Infections
| Article | Year |
|---|---|
A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Asparagine; Drug Carriers; Drug Compounding; Erythrocytes; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Mycoses; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Analysis | 2015 |